{"study_desc":{"title_statement":{"idno":"Vatu_Zambia","title":"Violence and Alcohol Treatment (VATU) trial: ZAMBIA"},"authoring_entity":[{"name":"Laura Murray","affiliation":"Johns Hopkins University (USA)"},{"name":"Stephanie Skavenski","affiliation":"Johns Hopkins University (USA)"},{"name":"Jeremy Kane","affiliation":"Johns Hopkins University (USA)"},{"name":"Phillip Chimphonda","affiliation":"  Serenity Harm Reduction Programme ( Zambia)"},{"name":"Sapphire Munthali","affiliation":"  Serenity Harm Reduction Programme ( Zambia)"}],"production_statement":{"funding_agencies":[{"name":"Department for International Development (UK)","abbreviation":"DFID(UK)","role":""}]},"study_info":{"abstract":"CETA is a scientifically-proven transdiagnostic intervention, combining treatments for a range of mental health issues (trauma, depression, anxiety, alcohol abuse) into a single model. CETA's modular, community-based approach addresses several mental health challenges in concert, enabling scale-up and sustainability in low-to middle-income environments.\nResearch Methods: A randomized controlled trial was conducted to explore implementing CETA as a strategy to reduce and prevent violence against women. In the past, there have been few rigorous trials on interventions for IPV with clinical inclusion criteria. CETA trial was implemented across 3 sites in Lusaka, the capital of Zambia. Two hundred and forty-eight (248) 'family units' participated: an adult woman, her adult male partner, and one identified youth (male or female, age 8-17). Families were eligible if 1) the adult female indicated moderate-to-severe amount of violence, 2) the adult male partner was identified as drinking alcohol at hazardous levels. For details of the study protocol: Global Mental Health (2017), 4, e18. doi:10.1017\/gmh.2017.10","coll_dates":[{"start":"2016-05-02","end":"2016-12-16","cycle":""}],"nation":[{"name":"Zambia","abbreviation":""}]},"method":{"study_class":"Randomised Control Trial"}}}